GLP-1 receptor agonists represent a major therapeutic class in the management of type 2 diabetes and obesity, with multiple agents now available offering distinct pharmacokinetic profiles and clinical outcomes. The primary GLP-1 medications in clinical use include semaglutide, tirzepatide, dulaglutide, and liraglutide, each available in formulations approved for diabetes, weight management, or both. Semaglutide is available as Ozempic for glycemic control and Wegovy for chronic weight management, while tirzepatide is marketed as Mounjaro for diabetes and Zepbound for weight loss. These agents differ fundamentally in their mechanism of action, with tirzepatide functioning as a dual GLP-1 and glucose-dependent insulinotropic peptide receptor agonist, whereas semaglutide and dulaglutide are selective GLP-1 agonists. Dosing schedules vary, with semaglutide and tirzepatide administered once weekly via subcutaneous injection, while dulaglutide is also dosed weekly but at fixed doses, and liraglutide requires daily administration.
Comparative efficacy data demonstrate that tirzepatide produces superior glycemic control and weight loss relative to selective GLP-1 agonists. In the SURPASS trial series, tirzepatide achieved HbA1c reductions of 2.0 to 2.5 percentage points and weight loss of 10 to 21 percent depending on dose, compared to 1.5 to 1.8 percentage point reductions in HbA1c and 5 to 10 percent weight loss with semaglutide at standard doses. For weight management specifically, semaglutide 2.4 mg demonstrates approximately 15 percent weight loss from baseline, while tirzepatide at higher doses achieves 20 to 22 percent weight loss. Cost considerations remain clinically relevant, with tirzepatide and semaglutide typically commanding higher copayments and insurance formulary restrictions compared to other agents. Dosing frequency influences adherence, and the weekly administration schedule of
Dealing with a condition like this?
Dr. Caplan has worked with 30,000+ patients on conditions like this. A consultation starts with your specific situation — not a generic protocol.
Book a consultation →💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- What is a GLP-1 medication and how does it work?
- What is the difference between Ozempic and Wegovy?
- Am I a good candidate for GLP-1 therapy?
- How often do I need to inject GLP-1 medication?
- What are the most common side effects of GLP-1 drugs?
- How long does it take to see weight loss results from GLP-1 therapy?
- Will I regain weight if I stop taking GLP-1 medication?
- How much do GLP-1 medications cost?
- Can I use GLP-1 medication if I have a history of thyroid cancer or pancreatitis?
- How does Mounjaro differ from Ozempic and Wegovy?
- Read next
FAQ
What is a GLP-1 medication and how does it work?
GLP-1 medications are injectable drugs that mimic a natural hormone your body makes to control blood sugar and appetite. They work by slowing digestion, helping your pancreas release insulin when needed, and signaling your brain that you are full.
What is the difference between Ozempic and Wegovy?
Ozempic and Wegovy are the same medication (semaglutide) but approved for different purposes. Ozempic is approved for type 2 diabetes, while Wegovy is approved for weight loss in people without diabetes.
Am I a good candidate for GLP-1 therapy?
You may be a candidate if you have type 2 diabetes, prediabetes, or excess weight that increases your health risk. Your doctor will review your medical history, kidney and liver function, and other medications to determine if GLP-1 is safe for you.
How often do I need to inject GLP-1 medication?
Most GLP-1 medications are injected once weekly under the skin, usually in the abdomen, thigh, or arm. Your doctor will show you how to inject properly and you can do it yourself at home.
What are the most common side effects of GLP-1 drugs?
The most common side effects are nausea, vomiting, and diarrhea, especially when starting the medication or increasing the dose. These effects often improve over time as your body adjusts to the medication.
How long does it take to see weight loss results from GLP-1 therapy?
Most people begin to notice gradual weight loss within 2 to 4 weeks, with more significant results typically seen after 8 to 12 weeks of consistent use. Results vary based on your starting weight, diet, exercise, and which medication you take.
Will I regain weight if I stop taking GLP-1 medication?
Weight regain can occur after stopping GLP-1 medication because your appetite and blood sugar control return to baseline. Working with your doctor on a long-term plan that includes lifestyle changes helps minimize weight regain.
How much do GLP-1 medications cost?
Costs vary widely depending on the specific drug, your insurance coverage, and whether you use coupons or patient assistance programs. Prices generally range from several hundred to over one thousand dollars per month without insurance.
Can I use GLP-1 medication if I have a history of thyroid cancer or pancreatitis?
No, GLP-1 medications are not recommended for people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia. You should discuss any history of pancreatitis with your doctor before starting GLP-1 therapy.
How does Mounjaro differ from Ozempic and Wegovy?
Mounjaro (tirzepatide) works slightly differently by targeting two hormone pathways instead of one, which may lead to greater blood sugar control and weight loss than some other GLP-1 drugs. Like other GLP-1 medications, it is injected once weekly.
